Navigation Links
PDL BioPharma Provides Third Quarter 2010 Revenue Guidance of Approximately $86 Million and Update to its Correspondence With Genentech
Date:9/1/2010

INCLINE VILLAGE, Nev., Sept. 1 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced revenue guidance for the third quarter ended September 30, 2010 of approximately $86 million, as compared with actual results of $71.4 million for the third quarter of 2009, a 20 percent year-over-year increase.  The growth is primarily driven by increased second quarter 2010 sales of Avastin®, Herceptin®, Lucentis® and Tysabri® for which PDL receives royalties in the third quarter of 2010.  Also included in third quarter 2010 guidance is $2.9 million earned on Eurodollar foreign currency hedging contracts that the Company initiated in January 2010.  The royalty payment from Genentech included royalties generated on both U.S. and ex-U.S. manufactured products and sales.

Sales of Avastin, Herceptin, Xolair and Lucentis are subject to a tiered royalty rate for product that is made or sold in the United States and a flat royalty rate of three percent for product that is manufactured and sold outside of the United States.  The net sales thresholds and the applicable royalty rates for product that is made or sold in the United States are outlined below: Royalty RateNet sales up to $1.5 billion

3.0%Net sales between $1.5 billion and $2.5 billion

2.5%Net sales between $2.5 billion and $4.0 billion

2.0%Net sales exceeding $4.0 billion

1.0%Reported sales of Avastin and Herceptin increased 11 percent and six percent, respectively, in the second quarter of 2010, when compared to the same period for the prior year. Roche recently reported that global sales of Avastin for advanced colorectal, breast, lung and kidney cancer, and for relapsed glioblastoma, rose 14 percent in the first half of 2010 driven by uptake in colorectal, breast and/or lung cancer.  Roche also reported that global sales of Herceptin
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Reportlinker Adds Advances in Biopharmaceutical Technology in China
2. PDL BioPharma Announces Retirement of $61.6 Million of 2.75% Convertible Notes due August 2023 for Common Stock
3. Therapure Biopharma Inc. Signs Biomanufacturing Contract with Diamedica Incorporated
4. Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life
5. Progenika Biopharma Grants Grifols World-Wide Distribution Rights for the BLOODCHIP® Genotyping Test for Blood Donors
6. Therapure Biopharma Inc. Signs Biomanufacturing Contract with ProChon Biotech Ltd.
7. Chinese Biopharmaceutical Association Holds 15th Annual Conference in Rockville, MD, June 12 - 13
8. IntraLinks Announces Partnership With SAFE-BioPharma; Will Provide Digital Identity Capabilities With its Life Sciences Solutions
9. PDL BioPharma to Announce First Quarter 2010 Financial Results and Hold Conference Call on April 29, 2010
10. PDL BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results and Provides First Quarter 2010 Revenue Guidance
11. ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 24, 2013 In a sneak ... suppliers will present technologies with applications in multiple ... SPIE Optics and Photonics symposium in ... SPIE, the international society for optics and photonics ... optical sciences and technology meeting in North America, ...
(Date:5/24/2013)... , May 24, 2013 Senomyx ... using proprietary taste science technologies to discover, develop, and ... David Linemeyer , Ph.D., the Company,s Vice President, ... President, Investor Relations & Corporate Communications, will present an ... 31, at 10:25 a.m. Eastern Time (7:25 a.m. Pacific ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 The Oklahoma ... And following its ravage, the mayor of Moore, one of ... new houses, said a report from cnn.com. Reaching out to ... victims complimentary Molderizer and Safe Shield to counter the looming ... report published on May 22, 2013, caused 24 deaths, My ...
(Date:5/23/2013)... May 24, 2013 Die Übersetzungen ... Bei der englischen Version handelt ... 91 % der Teilnehmer einer groß angelegten Asthmaumfrage halten ... laut GINA [*] -Definition [1] als kontrolliert gelten ... Asthma generell einer von vier Denkweisen zugeordnet werden können, ...
Breaking Biology Technology:See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 2See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 3See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 4SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Mayor of Oklahoma-Tornado-Impaired Town Proposes Storm Shelter Bill, My Cleaning Products Offers Complimentary Molderizer and Safe Shield to Help Victim with Looming Mold 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7
... at the Drake Hotel in Chicago, about 130 people ... due diligence providers gathered at the M&A Advisor conference ... markets ($10 million to $1 billion) of financing and ... of your brand and intellectual property" to "due diligence: ...
... Corp. has raised approximately $137 million in net proceeds ... global manufacturer of identification solutions, including signs and labels, issued ... per share. The company intends to use the net proceeds ... facility and for general corporate purposes, including potential future acquisitions. ...
... Corp ., the banking and payments technology subsidiary of ... final stages of acquiring VICOR, Inc. , a ... ,VICOR is being pursued, in part, to enable Metavante ... financial institutions so they can address the need to ...
Cached Biology Technology:Some great insights into the current Mergers & Acquisitions Market 2Some great insights into the current Mergers & Acquisitions Market 3Some great insights into the current Mergers & Acquisitions Market 4Some great insights into the current Mergers & Acquisitions Market 5
(Date:5/24/2013)... the immune system to combat metastatic cancer , ... destruction by the immune system. Stimulation of the immune ... are many factors that cause the immune system to ... that function to suppress the immune system response. In ... , researchers led by Ronald Levy at Stanford University ...
(Date:5/24/2013)... After studying noise in one French Quarter neighborhood ... levels exceeded municipal ordinances, Annette Hurley, PhD, Assistant Professor ... and Eric Arriaga, a third-year LSUHSC doctor of audiology ... their own hearing health. Their case study is published ... Hearing Practice Management ., "An important part of an ...
(Date:5/23/2013)... , Automated conserved noncoding sequence (CNS) discovery ... grasses , Within the genome of each species, ... little change in position and sequence over millions of ... of these evolutionarily stable sequences, so-called conserved noncoding sequences ... genes or the condensation of chromosomes, but the function ...
Breaking Biology News(10 mins):JCI early table of contents for May 24, 2013 2JCI early table of contents for May 24, 2013 3JCI early table of contents for May 24, 2013 4JCI early table of contents for May 24, 2013 5JCI early table of contents for May 24, 2013 6JCI early table of contents for May 24, 2013 7JCI early table of contents for May 24, 2013 8Please do try this at home 2Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3
... may be a crucial factor underlying the development of emphysema, ... found that in mice that have short telomeres, there was ... cigarette smoke," said Mary Armanios, MD, assistant professor of oncology ... appears online ahead of the print edition of the ...
... breakthrough in the development of a cable that will make ... quantum wire (AQW) will be a weave of metallic nanotubes ... It will be an ideal replacement for the nation,s copper-based ... 100 miles of transmission, said Rice chemist Andrew R. Barron, ...
... and singer Julie Andrews lost her singing voice following surgery ... to Steven Zeitels, a professor of laryngeal surgery at Harvard ... develop a new type of material that could be implanted ... 2002, he enlisted the help of MIT,s Robert Langer, the ...
Cached Biology News:Research links telomere length to emphysema risk 2'Amplified' nanotubes may power the future 2'Amplified' nanotubes may power the future 3New material could offer hope to those with no voice 2New material could offer hope to those with no voice 3
iNOS/NOS Type II Purified Anti-Mouse, Anti-Rat, Anti-Human clone Polyclonal, Isotype Rabbit Ig, 150 µg Consult technical datasheet for details....
Cell Culture Flask, 75 cm, treated polystyrene...
Cell Culture Flask, 75 cm, nontreated polystyrene...
... virtually every research laboratory, the revolutionary Luminex ... accurately, inexpensively and in real time enhancing ... analysis system includes the Luminex 100, the ... xMAP technology which enables you to simultaneously ...
Biology Products: